These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15782418)

  • 1. New anticoagulants: a pediatric perspective.
    Balasa VV
    Pediatr Blood Cancer; 2005 Nov; 45(6):741-52. PubMed ID: 15782418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The status of new anticoagulants.
    Bates SM; Weitz JI
    Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anticoagulants and the future of anticoagulation.
    Garcia D
    Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation therapy in children.
    Revel-Vilk S; Chan AK
    Semin Thromb Hemost; 2003 Aug; 29(4):425-32. PubMed ID: 14517754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anticoagulants & clinical trials.
    Haideri N; Patel H
    Mo Med; 2009; 106(1):60-4. PubMed ID: 19245126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term anticoagulation: the prospects for alternatives to warfarin.
    Ansell J
    Semin Vasc Surg; 2005 Sep; 18(3):134-8. PubMed ID: 16168888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
    Zikria JC; Ansell J
    Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging anticoagulants for the treatment of venous thromboembolism.
    Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of new anticoagulants.
    Anderson J; O'Donnell M
    Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin: from animal organ extract to designer drug.
    Middeldorp S
    Thromb Res; 2008; 122(6):753-62. PubMed ID: 17996279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary assessment of the critical differences between novel oral anticoagulants currently in development.
    McBride BF
    J Clin Pharmacol; 2005 Sep; 45(9):1004-17. PubMed ID: 16100294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anticoagulants in children: a review of recent studies and a look to the future.
    Young G
    Thromb Res; 2011 Feb; 127(2):70-4. PubMed ID: 21129768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
    Steffel J; Lüscher TF
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfractionated heparin therapy in infants and children.
    Newall F; Johnston L; Ignjatovic V; Monagle P
    Pediatrics; 2009 Mar; 123(3):e510-8. PubMed ID: 19221154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural and synthetic glycosaminoglycans. Molecular characteristics as the basis of distinct drug profiles].
    Alban S
    Hamostaseologie; 2008 Feb; 28(1-2):51-61. PubMed ID: 18278163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
    Merli G; Spyropoulos AC; Caprini JA
    Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anticoagulants.
    Bauer KA
    Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.